We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
321 hedge funds and large institutions have $3.5B invested in ADMA Biologics in 2024 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 124 increasing their positions, 104 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
179% more call options, than puts
Call options by funds: $43.8M | Put options by funds: $15.7M
33% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 57
19% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 104
5% more funds holding
Funds holding: 306 → 321 (+15)
3.24% less ownership
Funds ownership: 89.56% → 86.31% (-3.2%)
16% less capital invested
Capital invested by funds: $4.16B → $3.5B (-$663M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
321
Holders Change
+15
Holders Change %
+4.9%
% of All Funds
4.23%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.07%
New
76
Increased
124
Reduced
104
Closed
57
Calls
$43.8M
Puts
$15.7M
Net Calls
+$28.1M
Net Calls Change
-$2.79M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$57.7M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$54.2M |
| 3 |
D.E. Shaw & Co
New York
|
-$41.3M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$38.8M |
| 5 |
AIC
AWM Investment Company
New York
|
-$38.1M |
